Singapore markets open in 51 minutes
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,180.74 +52.95 (+1.03%) Dow
38,852.27 +176.59 (+0.46%) Nasdaq
16,349.25 +192.92 (+1.19%) Bitcoin USD
63,286.25 -802.17 (-1.25%) CMC Crypto 200
1,361.44 +48.81 (+3.72%)
ARS Pharmaceuticals, Inc. (SPRY)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.75 |
| Open | 9.75 |
| Bid | 9.43 x 200 |
| Ask | 9.50 x 400 |
| Day's range | 9.10 - 9.80 |
| 52-week range | 2.55 - 11.27 |
| Volume | |
| Avg. volume | 739,090 |
| Market cap | 944.72M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Barrons.com
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
RA Capital increased its stake in biopharmaceutical firm ARS. Bain Capital lowered its stake in pharmaceutical firm Nuvalent.
- Simply Wall St.
Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- Zacks
ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's What You Should Know
ARS Pharmaceuticals, Inc. (SPRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.